PLA
Showing 26 - 50 of 1,990
Peripherally Inserted Central Catheter Trial in Beijing (Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC
Recruiting
- Peripherally Inserted Central Catheter
- Arrowga+rd Blue Advance Protection PICC Placement
- Sham Comparator PICC placement
-
Beijing, Doncheng District, China
- +4 more
Jan 20, 2023
Thrombus Imaging and Treatment Analytics in Neurology
Not yet recruiting
- Thrombus, Brain
- Thrombosis
- thrombus imaging appearance
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 15, 2022
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Efficacy of Targeted Therapy for NSCLC
Recruiting
- Evaluation
- +2 more
- RecistTM criteria
-
Chongqing, Chongqing, ChinaCancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023
Solid Tumor Trial in Beijing (XH001+ sintilimab)
Recruiting
- Solid Tumor
- XH001+ sintilimab
-
Beijing, Beijing, ChinaPLA General Hospital
Jul 10, 2023
EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV Infection After Allogenic HSCT
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 3, 2023
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
Papillary Thyroid Microcarcinoma, Thyroid, Thyroid Cancer Trial in New York (Percutaneous Laser Ablation (PLA))
Recruiting
- Papillary Thyroid Microcarcinoma
- +2 more
- Percutaneous Laser Ablation (PLA)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 14, 2022
Microecology and Host Immunity in Severe COVID-19 Infection
Recruiting
- Microbiome,Immune Function, Critically Ill
-
Beijing, Beijign, ChinaPLA
Jan 2, 2023
Liquid Biopsy Signature to Detect Early-onset Gastric Cancer
Completed
- Gastric Cancer
- Measurement of levels of an exosome-based liquid biopsy signature
-
Beijing, Beijing, ChinaChinese PLA General Hospital Ethics Committee
Aug 29, 2023
Advanced Solid Tumor Trial in Beijing (QLF3108)
Recruiting
- Advanced Solid Tumor
-
Beijing, Beijing, ChinaChinese People's Liberation Army (PLA) General Hospital
Aug 29, 2023
Rectal Cancer Trial in Beijing, Shanghai, Chengdu (Dissection of the No.253 lymph node, Omitting the dissection of the No.253
Not yet recruiting
- Rectal Cancer
- Dissection of the No.253 lymph node
- Omitting the dissection of the No.253 lymph node
-
Beijing, Beijing, China
- +6 more
Nov 27, 2023
Acute Ischemic Stroke Trial in Nanjing, Chengdu (Dexmedetomidine, Midazolam)
Recruiting
- Acute Ischemic Stroke
-
Nanjing, None Selected, China
- +1 more
Nov 21, 2023
Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Lymphoma
- CD70-targeting CAR-T cells
-
Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 9, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- Best-Available Therapy(BAT) Regimen
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Oct 10, 2023
Associated With Postoperative Adverse Outcomes In The Older
Completed
- Frailty
- Frailty Index
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 14, 2023
The Surveillance of Hepatocellular Carcinoma
Recruiting
- Hepatocellular Carcinoma
- Imaging examination and/or blood test
-
Beijing, Beijing, China
- +1 more
Mar 17, 2022
Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)
Recruiting
- Solid Tumor, Adult
- CD70-targeting CAR-T cells
-
Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, ChinaChina
Jul 8, 2023
Pneumocystis Jirovecii Pneumonia Trial in Beijing (Radiomic model)
Active, not recruiting
- Pneumocystis Jirovecii Pneumonia
- Radiomic model
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jan 25, 2023
Long-term Peritoneal Dialysis Patients Who Eventually Develop
Active, not recruiting
- Ultrafiltration Failure
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 11, 2023
COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)
Recruiting
- COVID-19
- Renal Insufficiency, Chronic
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 6, 2023
LCI in Chronic Atrophic Gastritis and Early Gastric Cancer
Recruiting
- CAG - Chronic Atrophic Gastritis
- EGC - Early Gastric Cancer
- Compare color information and mucosal microvascular density
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Nov 21, 2023
Thoracoabdominal; Aortic, Aneurysm, Dissecting Trial in Beijing (Thoracoabdominal aortic stent system)
Recruiting
- Thoracoabdominal; Aortic, Aneurysm, Dissecting
- Thoracoabdominal aortic stent system
-
Beijing, Beijing, ChinaChinese PLA General Hospita
Mar 26, 2023
Safety Issues, Effect of Drug, Tolerance Trial in Beijing (MB07133)
Recruiting
- Safety Issues
- +2 more
-
Beijing, Beijing, ChinaFifth Medical Center of Chinese PLA General Hospital
Nov 17, 2023